PubMed Health⌕ Search

Biomedical subjects

O Hattori

Publications and source records attributed to O Hattori.

3 recordsLinked to original sources

Dual staining methods for carbohydrates using lectin-gold silver techniques.

Three dual staining methods were established for the histochemical detection of saccharide residues and acidic groupings of carbohydrates in light microscopy. The first method consisted of combined lectin-gold silver (LT-G-S) and alcian blue (AB) pH 1.0 techniques, whereas the second staining technique was composed of LT-G-S and AB pH 2.5 procedures. These two techniques were found to color saccharide residues and acidic groupings of carbohydrates in black and blue shades respectively, which exhibited a high contrast between the both. The third methods, LT1-G-S-LT2-PO-DAB techniques, yielded reaction products of blackish and yellowish brown shades, which represented the localizations of two different saccharide residues in one and the same section. According to the results of the experimental and control procedures, the present three dual staining methods are believed to be reliable, reproducible and unusually useful for light microscopic histochemical studies on acidic and non-acidic carbohydrates.

Animals↗

Effect of the new calcium antagonist (+/-)-(R*)-3-[(R*)-1-benzyl-3- piperidyl] methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5- pyridinedicarboxylate hydrochloride (KW-3049) on cardiac hypertrophy in spontaneously hypertensive rats.

Using spontaneously hypertensive rats (SHR), we studied the effects of a new calcium antagonist, (+/-)-(R*)-3-[(R*)-1-benzyl-3-piperidyl] methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate hydrochloride (KW-3049) on the development of hypertension and cardiac hypertrophy. When KW-3049 was administered orally to 5-week-old SHR, a stage before the onset of hypertension, for 12 consecutive weeks, it showed a dose-dependent and marked antihypertensive action. Administration of 3 mg/kg of KW-3049, once a day, significantly suppressed the rise in blood pressure to a similar extent to 15 mg/kg of nicardipine, twice a day. After 12 weeks of administration, the heart weight was decreased or tended to be decreased. Co-administration with propranolol markedly decreased the heart rate, but little affected the heart weight, suggesting changes in the heart rate during the long-term administration of KW-3049 did not largely affect cardiac hypertrophy. KW-3049 did not increase plasma renin activity (PRA) or plasma aldosterone concentration (PAC). There was no significant change in the myocardial DNA and RNA contents. These results suggest the clinical usefulness of KW-3049 as an antihypertensive drug.

Aldosterone↗